Font: Financial Modeling Prep • Mar 13, 2026
Adobe Inc. (NASDAQ:ADBE) is a leading software company known for its creative and digital marketing solutions. It competes with other tech giants like Microsoft and Salesforce. Recently, Jackson Ader from KeyBanc set a price target of $235 for Adobe, while its stock was trading at $254.25, indicating a potential downside of approximately -7.57%.
Adobe's stock has been experiencing volatility, with a recent 8% drop to $248.25 in pre-market trading. This decline follows the announcement of CEO Shantanu Narayen's decision to step down, which has overshadowed Adobe's strong fiscal first-quarter earnings. Despite exceeding expectations, the leadership change has raised investor concerns.
The market's reaction to Narayen's departure is significant, as Adobe's stock has already faced a year-to-date deficit of 38.5%. The news has led to at least nine analysts reducing their price targets, with Barclays downgrading the stock to "equal weight" and setting a new target of $275. This reflects the uncertainty surrounding Adobe's future leadership.
Adobe's stock has fluctuated between $248.01 and $256.70 during the day, with a current price of approximately $252.48. The company's market capitalization is around $103.64 billion, and its trading volume is about 6.07 million shares. Despite a high of $422.95 over the past year, Adobe recently hit a seven-year low of $244.28.
The software industry is undergoing rapid changes due to advancements in artificial intelligence, which adds to the uncertainty for Adobe. While the company's earnings have been strong, concerns about AI potentially impacting software services continue to weigh on investor sentiment.
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$4.95
-24.66%
|
|
ADTX§>
Aditxt, Inc.
|
$0.01
-30.81%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.27
-8.87%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$8.66
2.67%
|
|
TOVX§>
Theriva Biologics, Inc.
|
$0.32
29.36%
|
|
SMCI§>
Super Micro Computer, Inc.
|
$31.97
9.22%
|
|
HKIT§>
Hitek Global Inc.
|
$0.55
26.65%
|
|
INTC§>
Intel Corporation
|
$116.96
9.27%
|
|
PPCB§>
Propanc Biopharma, Inc.
|
$2.51
85.93%
|
|
RUBI§>
Rubico Inc.
|
$0.62
31.98%
|